Imperial College London


Faculty of MedicineNational Heart & Lung Institute

Clinical Project Manager



+44 (0)20 3313 6198t.cole




NIHR Imperial CRF, Room G20ICTEM buildingHammersmith Campus





Tom is a Clinical Projects Manager at the NIHR Imperial Clinical Research Facility, Hammersmith Hospital. He has >15 years of experience in clinical research, working on CTIMP and non-CTIMP studies in patients and healthy volunteers, as a member of investigator site teams and also with responsibility for sponsor-level activities such as:

  • Development of protocols and other study documents
  • Gaining and maintaining approvals
  • IMP supply
  • CRF design
  • Site set-up, management and close-out - both NHS and non-NHS sites
  • Monitoring
  • Participation in regulatory inspections and audits



Win Z, Weiner J, Listanco A, et al., 2021, Systematic evaluation of kinetics and distribution of muscle and lymph node activation measured by F-18-FDG- and C-11-PBR28-PET/CT imaging, and whole blood and muscle transcriptomics after immunization of healthy humans with adjuvanted and unadjuvanted vaccines, Frontiers in Immunology, Vol:11, ISSN:1664-3224, Pages:1-16

Folegatti PM, Ewer KJ, Aley PK, et al., 2020, Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial., The Lancet, Vol:396, ISSN:0140-6736, Pages:467-478

Sharma R, Valls PO, Inglese M, et al., 2020, [18F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancer, European Journal of Nuclear Medicine and Molecular Imaging, Vol:47, ISSN:0340-6997, Pages:1239-1251

Abraham S, Juel HB, Bang P, et al., 2019, Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial, Lancet Infectious Diseases, Vol:19, ISSN:1473-3099, Pages:1091-1100


Pinato DJ, Cole T, Bengsch B, et al., 2020, 750P - A phase Ib study of pembrolizumab following trans-arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): PETAL, Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Wiley, Pages:209A-210A, ISSN:0270-9139

More Publications